Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache

Neurology

Volumn 75, Issue 12, 2010, Pages 1098-1103

  Weatherall, M W ^a,c   Telzerow, A J ^a   Cittadini, E ^a   Kaube, H ^a,d   Goadsby, P J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHLORPROMAZINE; LYSINE ACETYLSALICYLATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; ASTHMA; BLEEDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EPIGASTRIC PAIN; FEMALE; HEADACHE; HEARTBURN; HEMATEMESIS; HOSPITAL PATIENT; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NAUSEA AND VOMITING; PAIN ASSESSMENT; PHOBIA; PRIORITY JOURNAL; RASH; SCORING SYSTEM; SIDE EFFECT; TERTIARY HEALTH CARE; TINNITUS; VISUAL ANALOG SCALE; VITAL CAPACITY; ADOLESCENT; CHEMICALLY INDUCED; DRUG EFFECTS; HEADACHE DISORDERS; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL RECORD; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SELECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; HEADACHE DISORDERS; HUMANS; INFUSIONS, INTRAVENOUS; INPATIENTS; MALE; MEDICAL RECORDS; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 77957224851     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f39a11     Document Type: Article

References (26)

1. Goadsby PJ. Pathophysiology of migraine. Neurol Clin North Am 2009;27:335-360.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-657.
3. Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol 2000;57:418-420.
4. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003;290:2443-2454.
5. Tepper SJ, Dahlof CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the landmark study. Headache 2004;44:856-864.
6. Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd edition (ICHD-II): revision of criteria for 8.2 medication-overuse headache. Cephalalgia 2005;25:460-465.
7. Goadsby PJ, Dodick D, Silberstein SD. Chronic Daily Headache for Clinicians. Hamilton, Canada: BC Decker Inc; 2005.
8. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener H-C. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-1014.
9. Katsarava Z, Fritsche G, Muessig M, Diener HC, Lim-mroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001;57:1694-1698.
10. Bhola R, Kaube H, Goadsby PJ. Role of a clinical nurse specialist (CNS) in an in-patient headache service in the UK. Cephalalgia 2004;24:1096-1097.
11. Kaube H, Hoskin KL, Goadsby PJ. Intravenous acetylsali-cylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache 1993;33:541-550.
12. Kaube H, Hoskin KL, Goadsby PJ. Acetylsalicylic acid inhibits cerebral cortical vasodilatation due to superior sagittal sinus stimulation in the cat. Eur J Neurol 1994; 1:141-146.
13. Kaube H, Hoskin KL, Edvinsson L, Goadsby PJ. Intravenous acetylsalicylic acid inhibits release of CGRP and response of cortical blood flow to stimulation of the superior sagittal sinus in the cat. Cephalalgia 1995;15(suppl 14): 107.
14. Goadsby PJ, Hoskin KL, Kaube H. Autoradiographic evaluation of acetylsalicylic acid distribution in the brainstem of the cat. In: Rose FC, ed. New Advances in Headache Research: 4. London: Smith-Gordon and Co Ltd; 1994:151.
15. Diener H-C; ASASUMAMIG Study Group. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine: a double-blind, double-dummy, randomized, multicenter, parallel group study. Cephalalgia 1999;19:581-588.
16. Limmroth V, May A, Diener HC. Lysine-acetylsalicylic acid in acute migraine attacks. Eur Neurol 1999;41: 88-93.
17. Leniger T, Pageler L, Stude P, Diener HC, Limmroth V. Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks. Headache 2005;45:42-46.
18. Lane PL, McLellan BA, Baggoley CJ. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 1989;18:360-365.
19. Welch KMA, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 2002;15: 287-295.
20. Evers S, Goadsby PJ. Hypnic headache: a literature review on clinical features, pathophysiology, treatment. Neurology 2003;60:905-909.
21. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006;26:1192-1198.
22. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006;26:1097-1105.
23. Weatherall MW. Chronic daily headache. Practical Neurology 2007;7:212-221.
24. Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA): a prospective clinical study of SUNCT and SUNA. Brain 2006;129:2746-2760.
25. Goadsby PJ, Boes CJ. New daily persistent headache. J Neurol Neurosurg Psychiatry 2002;72(suppl 6):ii6-ii9.
26. Levy M, Matharu MS, Meeran K, Powell M, Goadsby PJ. The clinical characteristics of headache in patients with pituitary tumours. Brain 2005;128:1921-1930.